Document Detail


Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization.
MedLine Citation:
PMID:  20688531     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Development of new hepaticoenteric anastomotic vessels may occur after endovascular skeletonization of the hepatic artery. Left untreated, they can serve as pathways for nontarget radioembolization. The authors reviewed the incidence, anatomy, management, and significance of collateral vessel formation in patients undergoing radioembolization.
MATERIALS AND METHODS: One hundred thirty-eight treatments performed on 122 patients were reviewed. Each patient underwent a preparatory digital subtraction angiogram (DSA) and embolization of all hepaticoenteric vessels in preparation for yttrium-90 ((90)Y) administration. Successful skeletonization was verified by C-arm computed tomography (CACT) and technetium-99m macroaggregated albumin ((99m)TcMAA) scintigraphy. During the subsequent treatment session, DSA and CACT were repeated before administration of (90)Y, and the detection of extrahepatic perfusion prompted additional embolization.
RESULTS: Forty-two patients (34.4%) undergoing 43 treatments (31.2%) required adjunctive embolization of hepaticoenteric vessels immediately before (90)Y administration. Previous scintigraphy findings showed extrahepatic perfusion in only three cases (7.1%). Vessels were identified by DSA in 54.1%, by CACT in 4.9%, or required both in 41.0%. The time interval between angiograms did not correlate with risk of requiring reembolization (P = .297). A total of 19.7% of vessels were new collateral vessels not visible during the initial angiography. Despite reembolization, three patients (7.1%) had gastric or duodenal ulceration, compared with 1.3% who never had visible collateral vessels, all of whom underwent whole-liver treatment with resin microspheres (P = .038).
CONCLUSIONS: Development of collateral hepaticoenteric anastomoses occurs after endovascular skeletonization of the hepatic artery. Identified vessels may be managed by adjunctive embolization, but patients appear to remain at increased risk for gastrointestinal complications.
Authors:
Mohamed H K Abdelmaksoud; Gloria L Hwang; John D Louie; Nishita Kothary; Lawrence V Hofmann; William T Kuo; David M Hovsepian; Daniel Y Sze
Publication Detail:
Type:  Journal Article     Date:  2010-08-04
Journal Detail:
Title:  Journal of vascular and interventional radiology : JVIR     Volume:  21     ISSN:  1535-7732     ISO Abbreviation:  J Vasc Interv Radiol     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-30     Completed Date:  2010-12-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203369     Medline TA:  J Vasc Interv Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1385-95     Citation Subset:  IM    
Copyright Information:
Copyright 2010 SIR. Published by Elsevier Inc. All rights reserved.
Affiliation:
Division of Interventional Radiology, H-3646 Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305-5642, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Angiography, Digital Subtraction
Brachytherapy* / adverse effects
California
Collateral Circulation*
Embolization, Therapeutic* / adverse effects
Female
Gastrointestinal Diseases / etiology
Hepatic Artery / physiopathology*,  radiography,  radionuclide imaging
Humans
Infusions, Intra-Arterial
Liver Circulation*
Liver Neoplasms / blood supply*,  radiography,  radionuclide imaging,  radiotherapy*
Male
Middle Aged
Radiopharmaceuticals / administration & dosage*,  adverse effects,  diagnostic use
Retrospective Studies
Risk Assessment
Risk Factors
Technetium Tc 99m Aggregated Albumin / diagnostic use
Time Factors
Tomography, X-Ray Computed
Treatment Outcome
Young Adult
Yttrium Radioisotopes / administration & dosage*,  adverse effects
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 0/Technetium Tc 99m Aggregated Albumin; 0/Yttrium Radioisotopes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Activation level of extensor carpi ulnaris affects wrist and elbow acceleration responses following ...
Next Document:  Temperature isotherms during pulmonary cryoablation and their correlation with the zone of ablation.